Showing results (181-190 of 387) with videos related to

Sort By:
Pageof 39
Oncology Reports|April 22, 2008
Dual anti-cancer effects of weekly intraperitoneal docetaxel in treatment of advanced gastric cancer patients with peritoneal carcinomatosis: a feasibility and pharmacokinetic studySachio Fushida, Jun Kinoshita, Yasumichi Yagi, et al.
Japanese Journal of Clinical Oncology|June 29, 2006
A randomized phase III trial of postoperative adjuvant therapy with S-1 alone versus S-1 plus PSK for stage II/IIIA gastric cancer: Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC)Yuji Ueda, Takashi Fujimura, Shinichi Kinami, et al.
World Journal of Gastroenterology|January 20, 2022
Life prognosis of sentinel node navigation surgery for early-stage gastric cancer: Outcome of lymphatic basin dissectionShinichi Kinami, Naohiko Nakamura, Tomoharu Miyashita, et al.
IJU Case Reports|July 14, 2021
Prominent response to platinum-based chemotherapy in a patient with BRCA2 mutant-neuroendocrine prostate cancer and MDM2 amplificationTatsuaki Daimon, Takeo Kosaka, Hiroshi Hongo, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 12, 2008
[Giant lymphocele arising after extraperitoneal laparoscopic radical prostatectomy]Hiroshi Mikami, Keiichi Ito, Hidehiko Yoshii, et al.
The Journal of Biological Chemistry|September 8, 2012
Optimal ratio of transcription factors for somatic cell reprogrammingGo Nagamatsu, Shigeru Saito, Takeo Kosaka, et al.
The American Journal of Pathology|January 10, 2012
Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancerSuguru Shirotake, Akira Miyajima, Takeo Kosaka, et al.
International Journal of Oncology|May 13, 2015
Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer modelMasashi Matsushima, Eiji Kikuchi, Kazuhiro Matsumoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 1, 2024
Loss of phosphatase and tensin homolog expression castration-sensitive prostate cancer predicts outcomes in men after prostatectomyYoshinori Yanai, Shuji Mikami, Yota Yasumizu, et al.
Human Pathology|April 13, 2016
The prognostic significance of OCT4 expression in patients with prostate cancerTakeo Kosaka, Shuji Mikami, Shunsuke Yoshimine, et al.
Pageof 39